Sign In
Buy DXCM
$83.02
+0.360 (+0.436%)
At Close: Aug 06, 2026
DexCom, Inc. (NASDAQ:DXCM) to Post Q3 2022 Earnings of $0.87 Per Share, William Blair Forecasts
08:22am, Tuesday, 16'th Nov 2021 Dakota Financial News
DexCom, Inc. (NASDAQ:DXCM) Equities research analysts at William Blair increased their Q3 2022 earnings estimates for DexCom in a note issued to investors on Friday, November 12th. William Blair analyst M. Kaczor now anticipates that the medical device company will post earnings per share of $0.87 for the quarter, up from their previous forecast []
Soleus Capital Management, L.P. Buys DICE Therapeutics Inc, United Therapeutics Corp, Flexion ...
11:38pm, Monday, 15'th Nov 2021 GuruFocus
Related Stocks: LNTH , CDNA , SRDX , SIEN , EPIX , NPCE , DICE , UTHR , FLXN , ENTA , ORGO , NRIX , MDXG , RVMD , TKNO , GLTO , PODD , DXCM ,
Earnings Estimates Rising for DexCom (DXCM): Will It Gain?
01:46pm, Tuesday, 02'nd Nov 2021
DexCom (DXCM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
What's Happening With Dexcom Stock?
08:00am, Tuesday, 02'nd Nov 2021
The stock price of Dexcom, best known for its continuous glucose monitoring systems, has seen a rise of 10% last week, while it is up 14% in a month. The recent rise can be attributed to upbeat Q3 res
DexCom (DXCM) Q3 Earnings and Revenues Surpass Estimates
12:14pm, Friday, 29'th Oct 2021
DexCom's (DXCM) third-quarter results benefit from domestic and international revenue growth and solid new customer additions.
Dexcom Q3 Earnings Beat Street, Raises FY21 Outlook Ahead Of G7 Launch
12:02pm, Friday, 29'th Oct 2021
Dexcom Inc's (NASDAQ: DXCM) Q3 adjusted EPS of $0.89 though lower than $0.94 posted a year ago, came in sharply above the consensus of $0.63. Sales increased 30% Y/Y to $650.20 million, surpassing
DexCom, Inc. (DXCM) CEO Kevin Sayer on Q3 2021 Results - Earning Call Transcript
09:50pm, Thursday, 28'th Oct 2021
DexCom, Inc. (DXCM) CEO Kevin Sayer on Q3 2021 Results - Earning Call Transcript
DexCom (DXCM) Surpasses Q3 Earnings and Revenue Estimates
07:06pm, Thursday, 28'th Oct 2021
DexCom (DXCM) delivered earnings and revenue surprises of 43.55% and 6.15%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
5 S&P 500 Stocks to Buy Ahead of Q3 Earnings This Week
11:52am, Tuesday, 26'th Oct 2021
Five big S&P 500 companies (market capital > $45 billion) are slated to release third-quarter earnings results this week. These are: COF, DXCM, XOM, AFL and TMO.
Dexcom Expands Time in Range Initiative with Nick Jonas to Help Improve the Lives of People with Diabetes in the UK
04:00am, Wednesday, 13'th Oct 2021
LONDON--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in continuous glucose monitoring for people with diabetes, today announced the UK launch of its Time in Range Campaign, an awaren
Got $1,000? These 2 High-Growth Stocks Are Screaming Buys Right Now
11:30am, Tuesday, 12'th Oct 2021
Both companies are in industries with strong opportunity ahead.
Here's Why You Should Add DexCom (DXCM) Stock to Your Portfolio
12:56pm, Thursday, 07'th Oct 2021
Investors continue to be optimistic about DexCom (DXCM) owing to its slew of favorable coverage decisions for its G6 CGM System.
Stocks Rebound, But Will Rally Attempt Have Legs? Datadog, Microsoft, Dexcom Show Strength
04:11pm, Tuesday, 05'th Oct 2021
Stocks rebound, but will rally attempt have legs? Datadog, Microsoft, Dexcom show strength.
Dexcom Schedules Third Quarter 2021 Earnings Release and Conference Call for October 28, 2021 at 4:30 p.m. Eastern Time
08:45am, Tuesday, 05'th Oct 2021
SAN DIEGO--(BUSINESS WIRE)--Dexcom Schedules Third Quarter 2021 Earnings Release and Conference Call for October 28, 2021 at 4:30 p.m. Eastern Time.
Dexcom's (DXCM) G6 CGM System Gets Coverage in Manitoba
01:20pm, Monday, 04'th Oct 2021
Dexcom's (DXCM) CGM System is expected to simplify diabetes management due to increasing access to the life changing technology.
